Actionable news
0
All posts from Actionable news
Actionable news in OTIC: OTONOMY Inc,

BRIEF-Otonomy reports positive results from averts-2 phase 3 trial of otividex™ in patients with ménière's disease

Nov 8 (Reuters) - Otonomy Inc

* Otonomy reports positive results from Averts-2 Phase 3 trial of Otividex™ in patients with Ménière’s disease

* Otonomy reports positive results from Averts-2 Phase 3 trial of Otividex™ in patients with Ménière’s disease

* Otonomy Inc - ‍achieved primary endpoint in study​

* Otonomy Inc - ‍company plans to meet with FDA to discuss results of study and clinical requirements for registration​

* Otonomy Inc - ‍otividex was generally well-tolerated with no drug-related serious adverse events observed​ Source text for Eikon: Further company coverage:


More